269 related articles for article (PubMed ID: 30077738)
1. Sphk2 RNAi nanoparticles suppress tumor growth via downregulating cancer cell derived exosomal microRNA.
Liang J; Zhang X; He S; Miao Y; Wu N; Li J; Gan Y
J Control Release; 2018 Sep; 286():348-357. PubMed ID: 30077738
[TBL] [Abstract][Full Text] [Related]
2. Polo-like Kinase 1-targeting Chitosan Nanoparticles Suppress the Progression of Hepatocellular Carcinoma.
Wang D; Chang R; Wang G; Hu B; Qiang Y; Chen Z
Anticancer Agents Med Chem; 2017; 17(7):948-954. PubMed ID: 27671301
[TBL] [Abstract][Full Text] [Related]
3. Oral delivery of shRNA and siRNA via multifunctional polymeric nanoparticles for synergistic cancer therapy.
Han L; Tang C; Yin C
Biomaterials; 2014 May; 35(15):4589-600. PubMed ID: 24613049
[TBL] [Abstract][Full Text] [Related]
4. A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapy.
Ding Y; Wang W; Feng M; Wang Y; Zhou J; Ding X; Zhou X; Liu C; Wang R; Zhang Q
Biomaterials; 2012 Dec; 33(34):8893-905. PubMed ID: 22979990
[TBL] [Abstract][Full Text] [Related]
5. Cationic lipid nanoparticles for therapeutic delivery of siRNA and miRNA to murine liver tumor.
Hsu SH; Yu B; Wang X; Lu Y; Schmidt CR; Lee RJ; Lee LJ; Jacob ST; Ghoshal K
Nanomedicine; 2013 Nov; 9(8):1169-80. PubMed ID: 23727126
[TBL] [Abstract][Full Text] [Related]
6. Role of exosomes and exosomal microRNAs in hepatocellular carcinoma: Potential in diagnosis and antitumour treatments (Review).
Pan JH; Zhou H; Zhao XX; Ding H; Li W; Qin L; Pan YL
Int J Mol Med; 2018 Apr; 41(4):1809-1816. PubMed ID: 29328436
[TBL] [Abstract][Full Text] [Related]
7. Lipidation of polyethylenimine-based polyplex increases serum stability of bioengineered RNAi agents and offers more consistent tumoral gene knockdown in vivo.
Zhang QY; Ho PY; Tu MJ; Jilek JL; Chen QX; Zeng S; Yu AM
Int J Pharm; 2018 Aug; 547(1-2):537-544. PubMed ID: 29894758
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic potential of small interfering RNAs/micro interfering RNA in hepatocellular carcinoma.
Farra R; Grassi M; Grassi G; Dapas B
World J Gastroenterol; 2015 Aug; 21(30):8994-9001. PubMed ID: 26290628
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.
Varshosaz J; Farzan M
World J Gastroenterol; 2015 Nov; 21(42):12022-41. PubMed ID: 26576089
[TBL] [Abstract][Full Text] [Related]
10. Exosomes derived from miR-122-modified adipose tissue-derived MSCs increase chemosensitivity of hepatocellular carcinoma.
Lou G; Song X; Yang F; Wu S; Wang J; Chen Z; Liu Y
J Hematol Oncol; 2015 Oct; 8():122. PubMed ID: 26514126
[TBL] [Abstract][Full Text] [Related]
11. Exosomal miR-451a Functions as a Tumor Suppressor in Hepatocellular Carcinoma by Targeting LPIN1.
Zhao S; Li J; Zhang G; Wang Q; Wu C; Zhang Q; Wang H; Sun P; Xiang R; Yang S
Cell Physiol Biochem; 2019; 53(1):19-35. PubMed ID: 31162914
[TBL] [Abstract][Full Text] [Related]
12. Tumor-derived exosomes promote tumor self-seeding in hepatocellular carcinoma by transferring miRNA-25-5p to enhance cell motility.
Liu H; Chen W; Zhi X; Chen EJ; Wei T; Zhang J; Shen J; Hu LQ; Zhao B; Feng XH; Bai XL; Liang TB
Oncogene; 2018 Sep; 37(36):4964-4978. PubMed ID: 29786077
[TBL] [Abstract][Full Text] [Related]
13. Loss of exosomal miR-320a from cancer-associated fibroblasts contributes to HCC proliferation and metastasis.
Zhang Z; Li X; Sun W; Yue S; Yang J; Li J; Ma B; Wang J; Yang X; Pu M; Ruan B; Zhao G; Huang Q; Wang L; Tao K; Dou K
Cancer Lett; 2017 Jul; 397():33-42. PubMed ID: 28288874
[TBL] [Abstract][Full Text] [Related]
14. [Hepatocellular carcinoma-derived exosomal miRNA expression and its clinical value].
Wu MN; Sun JY; Yao M; Yao DF
Zhonghua Gan Zang Bing Za Zhi; 2020 Jan; 28(1):83-86. PubMed ID: 32023707
[TBL] [Abstract][Full Text] [Related]
15. Argonaute 2 promotes angiogenesis via the PTEN/VEGF signaling pathway in human hepatocellular carcinoma.
Ye ZL; Huang Y; Li LF; Zhu HL; Gao HX; Liu H; Lv SQ; Xu ZH; Zheng LN; Liu T; Zhang JL; Jin HJ; Qian QJ
Acta Pharmacol Sin; 2015 Oct; 36(10):1237-45. PubMed ID: 25937637
[TBL] [Abstract][Full Text] [Related]
16. Optimization of Transforming Growth Factor-β1 siRNA Loaded Chitosan-Tripolyphosphate Nanoparticles for the Treatment of Colorectal Cancer Hepatic Metastasis in a Mouse Model.
Fang JK; Chen L; Lu XG; Cao D; Guo LL; Zhang YS; Li LB; Zhang LF; Kuang YT; Wang SL
J Biomed Nanotechnol; 2016 Jul; 12(7):1489-1500. PubMed ID: 29337488
[TBL] [Abstract][Full Text] [Related]
17. Development of hybrid-type modified chitosan derivative nanoparticles for the intracellular delivery of midkine-siRNA in hepatocellular carcinoma cells.
Zhong J; Huang HL; Li J; Qian FC; Li LQ; Niu PP; Dai LC
Hepatobiliary Pancreat Dis Int; 2015 Feb; 14(1):82-9. PubMed ID: 25655295
[TBL] [Abstract][Full Text] [Related]
18. Biological functions and clinical applications of exosomal non-coding RNAs in hepatocellular carcinoma.
Li C; Xu X
Cell Mol Life Sci; 2019 Nov; 76(21):4203-4219. PubMed ID: 31300868
[TBL] [Abstract][Full Text] [Related]
19. Targeting HSP60 by subcutaneous injections of jetPEI/HSP60-shRNA destabilizes cytoplasmic survivin and inhibits hepatocellular carcinoma growth.
Huang YH; Lin KH; Yu JS; Wu TJ; Lee WC; Chao CC; Pan TL; Yeh CT
Mol Carcinog; 2018 Sep; 57(9):1087-1101. PubMed ID: 29672920
[TBL] [Abstract][Full Text] [Related]
20. CD73 specific siRNA loaded chitosan lactate nanoparticles potentiate the antitumor effect of a dendritic cell vaccine in 4T1 breast cancer bearing mice.
Jadidi-Niaragh F; Atyabi F; Rastegari A; Kheshtchin N; Arab S; Hassannia H; Ajami M; Mirsanei Z; Habibi S; Masoumi F; Noorbakhsh F; Shokri F; Hadjati J
J Control Release; 2017 Jan; 246():46-59. PubMed ID: 27993599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]